Aktie A0MLRP IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Immuno-Biological Laboratories Co., Ltd.

Aktien

A0MLRP

JP3921300004

4570

Markt geschlossen - Japan Exchange
Andere Börsenplätze
 08:00:00 02.05.2024 		% 5 Tage % 1. Jan.
460 JPY -0,43 % Intraday Chart für Immuno-Biological Laboratories Co., Ltd. -1,71 % -6,69 %
2023 Immuno-Biological Laboratories Co, Ltd. meldet Ergebnis für das am 31. März 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Immuno-Biological Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
An unknown buyer agreed to acquire unknown minority stake in CURED Co., Ltd. from Immuno-Biological Laboratories Co., Ltd.
An undisclosed buyer acquired 26.32% stake in Cell Remover Co., Ltd. from Immuno-Biological Laboratories Co., Ltd..
CURED Co., Ltd. announced that it has received ¥598.4 million in funding from Immuno-Biological Laboratories Co., Ltd.
CURED Co., Ltd. announced that it expects to receive ¥598.4 million in funding from Immuno-Biological Laboratories Co., Ltd.
Neo Silk Cosmetics Co., Ltd. announced that it has received ¥40 million in funding from Immuno-Biological Laboratories Co., Ltd.
Neo Silk Cosmetics Co., Ltd announced that it expects to receive ¥40 million in funding from Immuno-Biological Laboratories Co., Ltd.
Transgenic Inc. Enters into Joint Research Agreement with Immuno-Biological Laboratories Co. Ltd
Immuno-Biological Laboratories Co., Ltd. announced that it has received ¥1.4 billion in funding from Whiz Partners Inc.
Immuno-Biological Laboratories Co., Ltd. announced that it expects to receive ¥1.39 billion in funding from Whiz Partners Inc.
CURED Co., Ltd. announced that it has received ¥159.6 million in funding from Trans Genic Inc., Immuno-Biological Laboratories Co., Ltd.
CURED announced that it expects to receive ¥159.6 million in funding from Trans Genic Inc. and Immuno-Biological Laboratories Co., Ltd.
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it has received ¥100 million in funding from Trans Genic Inc., Immuno-Biological Laboratories Co., Ltd.
Hideki Egawa cancelled the acquisition of 79.6 % stake in M Cosmetics Co., Ltd. from Immuno-Biological Laboratories Co., Ltd., Mitsuru Onishi and others.
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it expects to receive ¥100 million in funding from Trans Genic Inc., Immuno-Biological Laboratories Co., Ltd.
Immuno-Biological Laboratories Co., Ltd. announced that it has received ¥406.31 million in funding from Trans Genic Inc., Merrill Lynch Japan Securities Co., Ltd., Investment Arm.
Immuno-Biological Laboratories Co., Ltd. announced that it expects to receive ¥406.31 million in funding from Trans Genic Inc., Merrill Lynch Japan Securities Co., Ltd., Investment Arm.
Hideki Egawa signed a contract to acquire 79.6 % stake in M Cosmetics Co., Ltd. from Immuno-Biological Laboratories Co., Ltd., Mitsuru Onishi and others for ¥20.6 million.
Xseed High Growth I managed by Japan Asia Investment Co. Ltd. acquired Skylight Biotech Inc.
Astellas Pharma and Immuno-Biological Conclude Collaborative Research Agreement
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0MLRP Aktie
  4. Nachrichten Immuno-Biological Laboratories Co., Ltd.
  5. Andere Sprachen